HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Clinical trials for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could 5 radiation sessions replace 30 for skin cancer patients?
Disease control Recruiting nowThis study tests if a shorter course of radiation (5 sessions) works as well as the standard longer course (20-30 sessions) for people with skin cancer in the head and neck area after surgery. About 90 adults who have had their cancer removed will be enrolled. The goal is to see …
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: David Palma • Aim: Disease control
Last updated May 26, 2026 06:31 UTC
-
New combo therapy aims to shrink head and neck tumors
Disease control Recruiting nowThis study tests whether adding an experimental drug called VS-101 to standard chemoradiotherapy helps control head and neck cancer better than standard treatment alone. About 30 adults with squamous cell carcinoma of the mouth, throat, or voice box will take part. The main goal …
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: VSPharmTech Co.,Ltd. • Aim: Disease control
Last updated May 26, 2026 06:23 UTC
-
New drug cocktail shows promise for tough head and neck cancers
Disease control Recruiting nowThis study tests a new combination of drugs given before surgery for people with advanced head and neck cancer. The goal is to see if the combo can shrink tumors enough to make surgery easier or more effective. About 76 adults with stage III-IV cancer will receive the treatment a…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated May 26, 2026 06:21 UTC
-
New shot targets tough cancers: early trial seeks 150 patients
Disease control Recruiting nowThis early-stage study tests a new drug called SH009 in about 150 people with advanced solid tumors (like liver, lung, or breast cancer) that have not responded to standard treatments. The main goal is to see if the drug is safe and can shrink tumors. Researchers will also measur…
Matched conditions: HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated May 18, 2026 12:11 UTC